Head-To-Head Survey: TerrAscend (OTCMKTS:TRSSF) vs. Grown Rogue International (OTCMKTS:GRUSF)

Grown Rogue International (OTCMKTS:GRUSF) and TerrAscend (OTCMKTS:TRSSF) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, risk, valuation, profitability, earnings, analyst recommendations and institutional ownership.

Profitability

This table compares Grown Rogue International and TerrAscend’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Grown Rogue International	-1.70%	-3.71%	-1.67%
TerrAscend	-125.03%	-6.66%	-3.07%

Analyst Recommendations

This is a breakdown of current ratings and price targets for Grown Rogue International and TerrAscend, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Grown Rogue International	0	0	0	0	N/A
TerrAscend	0	1	2	0	2.67

Insider and Institutional Ownership

9.3% of Grown Rogue International shares are held by institutional investors. Comparatively, 0.0% of TerrAscend shares are held by institutional investors. 23.2% of Grown Rogue International shares are held by insiders. Comparatively, 32.9% of TerrAscend shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Valuation and Earnings

This table compares Grown Rogue International and TerrAscend’s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Grown Rogue International	$23.35 million	6.00	-$130,000.00	$0.01	70.49
TerrAscend	$247.83 million	1.67	-$329.91 million	N/A	N/A

Grown Rogue International has higher earnings, but lower revenue than TerrAscend.

Risk & Volatility

Grown Rogue International has a beta of 0.54, meaning that its stock price is 46% less volatile than the S&P 500. Comparatively, TerrAscend has a beta of 2.89, meaning that its stock price is 189% more volatile than the S&P 500.

Summary

Grown Rogue International beats TerrAscend on 6 of the 10 factors compared between the two stocks.

About Grown Rogue International

Grown Rogue International Inc., together with its subsidiaries, produces and sells cannabis products in the United States. It offers a range of cultivars for consumers, such as indicas, sativas, and hybrids; strain-specific prepackaged flowers; and pre-roll pack products, as well as provides consulting services. The company sells its products through direct-to-retail delivery and third-party delivery, wholesalers, and processors. Grown Rogue International Inc. is headquartered in Medford, Oregon.

About TerrAscend

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis-infused artisan edibles. It also operates retail dispensaries under the Apothecarium brand name in California, Pennsylvania, and New Jersey. In addition, the company owns various synergistic businesses under Gage Growth, Pinnacle, TerrAscend NJ, Ilera Healthcare, HMS Health and HMS Processing, Valhalla Confections, State Flower, Arise Bioscience Inc., and TerrAscend Canada brands. It serves medical and legal adult-use markets. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.